Provided by Tiger Fintech (Singapore) Pte. Ltd.

ALPHAMAB-B

10.060
+0.1401.41%
Volume:2.68M
Turnover:26.97M
Market Cap:9.76B
PE:53.15
High:10.210
Open:9.910
Low:9.800
Close:9.920
52wk High:15.750
52wk Low:3.050
Shares:970.00M
HK Float Shares:970.00M
Volume Ratio:0.64
T/O Rate:0.28%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.189
ROE:13.37%
ROA:5.22%
PB:4.80
PE(LYR):53.15
PS:11.34

Loading ...

Hong Kong Stock Buyback Summary | November 10

Stock News
·
Nov 10

ALPHAMAB-B Plans to Repurchase Shares Worth Up to HKD 30 Million

Deep News
·
Nov 09

BRIEF-Alphamab Oncology To Repurchase Shares Up To HK$30 Million

Reuters
·
Nov 07

Alphamab Oncology (9966) Announces On-Market Share Repurchase up to HK$30 Million

Bulletin Express
·
Nov 07

Alphamab Oncology repurchases 1,681,000 shares

Reuters
·
Nov 07

Alphamab Oncology - to Repurchase Shares up to HK$30 Mln

THOMSON REUTERS
·
Nov 07

Alphamab Oncology (09966) Announces Share Repurchase Update

Bulletin Express
·
Nov 07

ALPHAMAB-B (09966) Repurchases 560,000 Shares for HK$5.261 Million on November 7

Stock News
·
Nov 07

Alphamab Oncology Files HKEX Disclosure on Repurchase of 560,000 Shares at HK$9.39 Each

Reuters
·
Nov 07

Alphamab Oncology's (HKG:9966) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Simply Wall St.
·
Nov 05

HK Movers|Biotech Shares Soar. 3SBIO up 11%; RemeGen up 8%; SKB BIO up 7%; Junshi Bio up 5%; Hengrui Pharma and Innocare up 4%.

Tiger Newspress
·
Oct 31

HK Stock Buyback Summary | October 29

Stock News
·
Oct 29

Alphamab Oncology (09966) Announces Share Repurchase Totalling HKD 3.77 Million

Bulletin Express
·
Oct 28

ALPHAMAB-B (09966) Repurchases 320,000 Shares for HK$3.7684 Million on October 28

Stock News
·
Oct 28

Alphamab Oncology Files HKEX Disclosure on Repurchase of 320,000 Shares at HK$11.78 Each

Reuters
·
Oct 28

BRIEF-Alphamab Oncology Says JSKN003 Granted Fast Track Designation By U.S. FDA

Reuters
·
Oct 27

Alphamab Oncology (9966) Announces Key Fast Track Designation for JSKN003

Bulletin Express
·
Oct 27

ALPHAMAB-B (09966): JSKN003 Granted FDA Fast Track Designation for PROC Treatment

Stock News
·
Oct 27

Alphamab Oncology - Jskn003 Granted Fast Track Designation by U.S. FDA for Proc

THOMSON REUTERS
·
Oct 27

ALPHAMAB-B Grants 1.9902 Million Reward Shares

Deep News
·
Oct 27